Why is Jagsonpal Pharma falling/rising?

As of 04-Jul, Jagsonpal Pharmaceuticals Ltd is experiencing a price increase, currently at 231.35, reflecting a rise of 2.6 or 1.14%. The stock has shown strong performance today, outperforming its sector by 0.63%. It is trading above all its moving averages, indicating positive momentum. Over the past week, the stock has gained 5.14%, significantly outperforming the Sensex, which has declined by 0.74%. Additionally, the company has demonstrated robust financial health, with a low debt-to-equity ratio and consistent growth in operating profit at an annual rate of 42.15%. The company has also reported positive results for the last four consecutive quarters, contributing to a substantial one-year return of 74.21%, far exceeding the market's average returns.
In the broader market context, while Jagsonpal Pharmaceuticals has shown strong short-term performance, the overall market, represented by the Sensex, has had mixed results, with a 1-month return of 1.92% for the stock compared to a 3.01% gain for the benchmark. This indicates that while the stock is performing well relative to its sector and has a strong historical performance, the market conditions are not uniformly favorable. However, the recent decline in investor participation, with a 20.81% drop in delivery volume, could be a concern for future price movements, suggesting that while the stock is currently rising, there may be underlying factors that could affect its sustainability.